Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Silletti

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Cancer Research|July 1, 1991
Purification of B16-F1 melanoma autocrine motility factor and its receptorS Silletti, H Watanabe, V Hogan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2000
Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2A Pfeifer, T Kessler, S Silletti, et al.
Journal of the American Chemical Society|July 18, 2001
Identification of a novel class of small-molecule antiangiogenic agents through the screening of combinatorial libraries which function by inhibiting the binding and localization of proteinase MMP2 to integrin alpha(V)beta(3)D L Boger, J Goldberg, S Silletti, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2001
Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivoS Silletti, T Kessler, J Goldberg, et al.
International Journal of Oncology|May 17, 2011
Autocrine motility factor-receptor in human bladder-carcinoma - gene-expression, loss of cell-contact regulation and chromosomal mappingS Silletti, J Yao, J Sanford, et al.
Cell|February 26, 1998
Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activityP C Brooks, S Silletti, T L von Schalscha, et al.
Anticancer Research|November 1, 1996
Multiple use of a signal transduction pathway in tumor cell invasionJ Tímár, E Rásó, Z S Fazakas, et al.
The Journal of Biological Chemistry|July 15, 1991
Purification of human tumor cell autocrine motility factor and molecular cloning of its receptorH Watanabe, P Carmi, V Hogan, et al.
Cancer Research|April 15, 1996
Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasionJ Timar, M Trikha, K Szekeres, et al.
Annals of Hematology|March 4, 2003
Matrix metalloproteinase/integrin interactions as target for anti-angiogenic treatment strategiesT A Kessler, A Pfeifer, S Silletti, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cancer Research|July 1, 1991
Purification of B16-F1 melanoma autocrine motility factor and its receptorS Silletti, H Watanabe, V Hogan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2000
Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2A Pfeifer, T Kessler, S Silletti, et al.
Journal of the American Chemical Society|July 18, 2001
Identification of a novel class of small-molecule antiangiogenic agents through the screening of combinatorial libraries which function by inhibiting the binding and localization of proteinase MMP2 to integrin alpha(V)beta(3)D L Boger, J Goldberg, S Silletti, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2001
Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivoS Silletti, T Kessler, J Goldberg, et al.
International Journal of Oncology|May 17, 2011
Autocrine motility factor-receptor in human bladder-carcinoma - gene-expression, loss of cell-contact regulation and chromosomal mappingS Silletti, J Yao, J Sanford, et al.
Cell|February 26, 1998
Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activityP C Brooks, S Silletti, T L von Schalscha, et al.
Anticancer Research|November 1, 1996
Multiple use of a signal transduction pathway in tumor cell invasionJ Tímár, E Rásó, Z S Fazakas, et al.
The Journal of Biological Chemistry|July 15, 1991
Purification of human tumor cell autocrine motility factor and molecular cloning of its receptorH Watanabe, P Carmi, V Hogan, et al.
Cancer Research|April 15, 1996
Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasionJ Timar, M Trikha, K Szekeres, et al.
Annals of Hematology|March 4, 2003
Matrix metalloproteinase/integrin interactions as target for anti-angiogenic treatment strategiesT A Kessler, A Pfeifer, S Silletti, et al.
Pageof 3